Advertisement
UK markets close in 5 hours 31 minutes
  • FTSE 100

    8,091.99
    +51.61 (+0.64%)
     
  • FTSE 250

    19,727.11
    +7.74 (+0.04%)
     
  • AIM

    755.22
    +0.53 (+0.07%)
     
  • GBP/EUR

    1.1665
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2512
    +0.0049 (+0.40%)
     
  • Bitcoin GBP

    51,103.95
    -1,930.00 (-3.64%)
     
  • CMC Crypto 200

    1,360.99
    -21.59 (-1.56%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.65
    -0.16 (-0.19%)
     
  • GOLD FUTURES

    2,338.30
    -0.10 (-0.00%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,986.66
    -102.04 (-0.56%)
     
  • CAC 40

    8,047.29
    -44.57 (-0.55%)
     

United States Infection Imaging Services Market Report 2022-2030: Increased Adoption to Identify a Range of Infections Bodes Well for the Sector

Company Logo
Company Logo

U.S. Infection Imaging Services Market

U.S. Infection Imaging Services Market
U.S. Infection Imaging Services Market

Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "U.S. Infection Imaging Services Market Size, Share & Trends Analysis Report by Indication (Osteomyelitis, Acute Appendicitis, CAD, Colitis, Pneumonia, Tuberculosis), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The U.S. infection imaging services market size is expected to reach USD 42.99 billion by 2030, expanding at a CAGR of 4.3% from 2022 to 2030.

Medical imaging is increasingly being adopted to detect infections such as acute appendicitis, cardiovascular inflammation, tuberculosis, pneumonia, fever of unknown origin, osteomyelitis, systemic vascularity, musculoskeletal disorder, and cardiovascular inflammation.

ADVERTISEMENT

A rise in underlying diseases like diabetes, cancer, and obesity is the leading cause of these infections. For instance, the prevalence rate of osteomyelitis raised ~10% since the 1970s till date. The rise is attributed to the change in diagnostic patterns and the increase in the diabetic population.

A rise in the geriatric population and unhealthy lifestyles are factors responsible for the rise in infectious diseases. Appendicitis occurs in 7% of the U.S. population with an incidence rate of 1.1 cases per 1000 people per year.

Additionally, the rise in endocarditis is also associated with increased comorbid conditions, increased placement of medical devices, and injection drug use. The rate of endocarditis increases by approximately 4.1% per year in the European region and increases by 106% over a period of 18 years. Factors such as the rise in infectious diseases and several underlying conditions are expected to boost the adoption of effective diagnostic tools, fueling market growth.

Among all imaging modalities, nuclear medicine is showing promising results in the diagnosis of infectious diseases. It identifies crucial complementary information, allowing visualization of infectious pathophysiology beyond morphologic imaging.

Numerous research activities are conducted using nuclear medicine techniques as the detection of metabolic abnormalities is done precisely by these techniques and it preceded morphological changes identified by structural imaging. Nuclear medicine techniques also show promising results in the diagnosis of COVID-19 infection. Thus, nuclear medicine holds a great growth opportunity as an identification tool in infection imaging.

Labeling of autologous leukocytes of purified neutrophils with In-111-oxine or 99m-Tc-HMPAO and imaging at variable time points to detect inflammatory bowel disease like Crohn's disease and ulcerative colitis. Thus, the adoption of nuclear medicine is rapidly increasing among end users and researchers to effectively and quickly diagnose critical disease conditions.

The increased use of PET/CT and PET/MRI is also influencing the industry's growth. However, the outbreak of COVID-19 has led to a decline in diagnostic activities involving the detection of infectious diseases using imaging modalities and national lockdowns of universities and research institutes, halting numerous research activities in this space. This led to a decline in 2020.

U.S. Infection Imaging Services Market Report Highlights

  • The acute appendicitis segment dominated the market for U.S. infection imaging services and accounted for the largest revenue share of 24.06% in 2021. It is further expected to continue its dominance over the forecast period

  • The atherosclerosis segment is expected to register the fastest CAGR of 4.6% during the forecast period. The need for early and precise diagnosis for studying various diseases is expected to contribute to the growth of the segment

  • Osteomyelitis shows nonspecific symptoms, and physical examination and laboratory results often delay identification. Techniques like unenhanced MRI can be used to identify tissue changes and the involvement of surrounding bones within two days of infection onset

Competitive Analysis

  • Rayus Radiology

  • Cms Diagnostic Services

  • Radnet, Inc

  • Dignity Health

  • Alliance Medical

  • Inhealth Group

  • Sonic Healthcare

  • Medica Group

  • Unilabs

  • Simonmed Imaging

Market Dynamics

Market Driver Analysis

  • Increasing prevalence of infectious diseases

  • Growing number of outpatient settings with imaging services

  • Growing awareness about medical imaging

Market Restraint Analysis

  • Radiation exposure

Near Infrared Imaging: Market Analysis Tools

  • Industry Analysis - Porter's

  • PESTEL Analysis

Major Deals & Strategic Alliances Analysis

Covid-19 Impact Analysis

For more information about this report visit https://www.researchandmarkets.com/r/68zord-s-infection?w=12

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900